Jonathan Bye
Lawyers
Filters
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
IDEAYA Biosciences $350 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Recursion Pharmaceuticals $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
IDEAYA Biosciences $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market